Examining the quality of health economic analyses submitted to the Pharmaceutical Benefits Board in Sweden. The first year.
Ramsberg
Joakim
J
Pharmaceutical Benefits Board, Solna, Sweden. joakim.ramsberg@lfn.se
Odeberg
Stefan
S
Engström
Andreas
A
Lundin
Douglas
D
D003362:Cost-Benefit Analysis; D017850:Economics, Pharmaceutical; D006801:Humans; D019057:Quality-Adjusted Life Years; D013548:Sweden